SCHEMBL985523

SCHEMBL985523

COc1c(Cl)cc(C(=O)Cl)cc1Cl

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
KDM4E B2RXH2 3/20 0.61
GAA P10253 1/20 0.61
TPMT P51580 1/20 0.56
TAS1R3 Q7RTX0 3/20 0.51
TAS1R1 Q7RTX1 3/20 0.51
TAS1R2 Q8TE23 3/20 0.51
HPGD P15428 2/20 0.51
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
RAB9A P51151 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
HSD17B10 Q99714 1/20 0.42
GALK1 P51570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27189692 0.88 ALDH1A1 (0.68) ALDH1A1KDM4EGAATPMTHPGD
SCHEMBL30822595 0.88 ALDH1A1 (0.68) ALDH1A1KDM4EGAATPMTHPGD
SCHEMBL10322834 0.87 ALDH1A1 (0.49) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL10323753 0.87 ALDH1A1 (0.49) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL5230795 0.85 ALDH1A1 (0.47) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL6343891 0.83 ALDH1A1 (0.61) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL1191343 0.83 TPMT (0.79) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL10323382 0.82 ALDH1A1 (0.45) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL10323754 0.82 ALDH1A1 (0.45) ALDH1A1KDM4EGAATPMTTAS1R3
SCHEMBL1191207 0.81 TPMT (0.54) ALDH1A1KDM4EGAATPMTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462557-A Preparation method of key intermediate of dorranolazine 上海博悦生物科技有限公司 2025-02-18 CN claimed
CN-122059904-A Synthetic multi-substituted method for preparing North Rate 重庆圣华曦药业股份有限公司 2026-05-19 CN disclosed
US-20250376457-A1 DICHLOROPHENOL HSD17B13 INHIBITORS AND USES THEREOF INIPHARM INC (US) 2025-12-11 US disclosed
CN-120398788-A Preparation method of key intermediate of dorranolazine 广东赛烽医药科技有限公司 2025-08-01 CN disclosed
CN-120058634-A Multi-tenor preparation method of mine 南京佰麦生物技术有限公司 2025-05-30 CN disclosed
CN-119591561-A Multi-tenor Synthesis method of thunder 上海药坦药物研究开发有限公司 2025-03-11 CN disclosed
CN-119504641-A Multi-tenor preparation method of mine 南京唯创远医药科技有限公司 2025-02-25 CN disclosed
CN-119462557-A Preparation method of key intermediate of dorranolazine 上海博悦生物科技有限公司 2025-02-18 CN disclosed
CN-119462557-A Preparation method of key intermediate of dorranolazine 上海博悦生物科技有限公司 2025-02-18 CN disclosed
CN-119080698-A Aroyl nuciferine derivative for inhibiting URAT1 as well as preparation method and application thereof 山东省农业科学院 2024-12-06 CN disclosed
WO-2013074930-A1 METHODS FOR TREATING LEISHMANIASIS HOWARD UNIVERSITY (US) 2013-05-23 WO disclosed
US-8367843-B2 Phenol derivative FUJI YAKUHIN CO., LTD. (JP) 2013-02-05 US disclosed
WO-2013016661-A1 METHOD FOR INHIBITING TRYPANSOMA CRUZI HOWARD UNIVERSITY (US) 2013-01-31 WO disclosed
EP-2484669-A1 NOVEL PHENOL DERIVATIVE Fuji Yakuhin Co., Ltd. (JP) 2012-08-08 EP disclosed
US-20120184587-A1 NOVEL PHENOL DERIVATIVE FUJI YAKUHIN CO., LTD. (JP) 2012-07-19 US disclosed
US-20120149778-A1 COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE 2012-06-14 US disclosed
EP-2440522-A2 AROYLTHIOUREA AND ARYLTHIOCARBONYLUREA DERIVATIVES University Court of The University of Dundee (GB) 2012-04-18 EP disclosed
US-7875631-B2 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed ANALYTECON S.A. (CH) 2011-01-25 US disclosed
WO-2010142956-A2 COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2010-12-16 WO disclosed
US-3964896-A Oxadiazole benzoic acid derivatives as herbicides UNIROYAL, INC. (US) 1976-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250376457-A1 DICHLOROPHENOL HSD17B13 INHIBITORS AND USES THEREOF HSD17B1, HSD17B3, HSD17B13 ALDH1A1 174/4885KDM4E 3481/4885GAA 739/4885
US-20120149778-A1 COMPOUNDS AR, NR5A1, NAT1 ALDH1A1 253/4885KDM4E 1689/4885GAA 2147/4885
US-20120184587-A1 NOVEL PHENOL DERIVATIVE XDH, REN, UTS2R ALDH1A1 74/4885KDM4E 2141/4885GAA 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.